View all news

INLEXZO™ (gemcitabine intravesical system) Assigned Permanent Billing Code, Supporting Access for Patients with Certain Bladder Cancers

04/01/2026

Multimedia Files:

View all news
Questions? Please contact us:
1-800-950-5089 investor-relations@its.jnj.com